Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
            
  Top » Catalog » Books » Most recent entries » Horizons in World Cardiovascular Research. Volume 2 Chapters » My Account  |  Cart Contents  |  Checkout   
Quick Find
  
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Small Business Innovation Research and Small Business Technology Transfer Programs: Background and Issues
$130.50
Shopping Cart more
0 items
Information
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Beneficial Clinical Effects of Perhexiline in Cardiac Patients: Multiple Biochemical Mechanisms, pp. 1-27
Tell A Friend
 
Tell someone you know about this product.
Beneficial Clinical Effects of Perhexiline in Cardiac Patients: Multiple Biochemical Mechanisms, pp. 1-27 $100.00
Authors:  (Yuliy Y. Chirkov, Aaron L. Sverdlov, John D. Horowitz, Basil Hetzel Institute, The Queen Elizabeth Hospital/Dept. of Medicine, The University of Adelaide, Australia)
Abstract:
Perhexiline, 2-(2,2-dicyclohexylethyl)piperidine, was originally developed as a prophylactic anti-anginal drug in the late 1960s. It was initially a popular and effective treatment for angina, having the almost unique property compared to other agents available at that time, of not inducing reductions in blood pressure or heart rate. Despite the initial success, its use diminished markedly due to the occurrence during long-term therapy of poorly understood side effects (neurotoxicity and hepatotoxicity), which later were shown to be associated with high plasma concentrations of perhexiline, occurring in patients with relatively slow hepatic metabolism of the drug. However, therapeutic plasma monitoring and associated dose adjustments have led to perhexiline's reintroduction into clinical practice. Recent clinical data have proved its safety and
maintained efficacy. Perhexiline reduced anginal frequency in patients with refractory angina. In patients with chronic heart failure, perhexiline improved peak exercise oxygen consumption, left ventricular ejection fraction, symptoms, resting and peak stress
myocardial function. Perhexiline also appears to be effective in suppressing symptoms in patients with acute coronary syndromes or with advanced and inoperable aortic valvular stenosis. Herein we discuss perhexiline's pharmacology with particular emphasis on its
mechanism(s) of action. 


Available Options:
Version:
Special Focus Titles
01.Biomarker Discovery and Biotherapeutics Applications of Photosynthetic Light-Harvesting and Bioluminescence Light-Emitting Chromophore-Protein Complexes in Stem Cell Biology and Regenerative Medicine.
02.Music and Hearing
03.The Mind of the Artist: Attention Deficit Hyperactivity Disorder, Autism, Asperger Syndrome & Depression
04.Interviews with Professor Donald Elder: The Presidents of the United States
05.Einstein and Others: Unification
06.War: An Introduction to Theories and Research on Collective Violence, 2nd Edition
07.Gambling: Cultural Attitudes, Motivations and Impact on Quality of Life
08.Autonomy, Altruism and Authority in Medical Ethics: Essays in Honor of Professor Shimon Glick
09.Child and Adolescent Health Issues (A Tribute to the Pediatrician Donald E Greydanus)
10.Beyond Diet and Depression, Volume 1: Basic Knowledge, Clinical Symptoms and Treatment of Depression
11.Research on Online/Offline Interventions in Mental Health: A Critical Review
12.Marine Oils (From Sea to Pharmaceuticals)
13.Cervical Spine Injuries: Epidemiology, Long-Term Outcomes and Complications
14.New Research Trends of Fluorite-Based Oxide Materials: From Basic Chemistry and Materials Science to Engineering Applications

Nova Science Publishers
© Copyright 2004 - 2015

Beneficial Clinical Effects of Perhexiline in Cardiac Patients: Multiple Biochemical Mechanisms, pp. 1-27